Case Study:
SYMBIO RESEARCH

I created this landing page for a New Statesman webinar featuring Patrick Ronan, Board Member at Symbio and Operating Partner at ARCHIMED, a global healthcare investment firm. The event examined how the Trump Administration sought to balance deregulation in healthcare with cost control, domestic manufacturing incentives, and reshaped agency oversight.

The objective was to communicate a complex and politically charged topic clearly and credibly for an audience of health policy, pharmaceutical, and regulatory professionals. I framed the discussion around the tension between deregulation and healthcare safety, positioning Mr. Ronan as a uniquely qualified insider with deep regulatory experience.

The copy introduced his credentials — including roles as CEO of Validant (now Eliquent Life Sciences), founder and CEO of Greenleaf Health, VP of Regulatory Policy at Novartis, and Chief of Staff at the FDA. These highlights established authority and credibility, while the content explored how policy changes affected drug development timelines, manufacturing incentives, and agency operations.

The final landing page positioned the New Statesman as a trusted host of expert-led policy dialogue, blending political insight with practical analysis for industry professionals.